Huaguan Biotechnology

Huaguan Biotechnology provides high-quality integrated drug research and development services for customers.

Active

Updated: Mar 15, 2026 ·

About

Huaguan Biotechnology is a company based in Beijing, China, focused on delivering integrated drug research and development services. The firm operates within the biotechnology sector, providing high-quality solutions to support pharmaceutical advancements for its customers. Its services are designed to cover various aspects of the drug development process.

Founded in 2017, Huaguan Biotechnology has established itself as a service provider in the Chinese biotechnology ecosystem. The company has successfully raised capital, including a Series C financing round that secured hundreds of millions of RMB, enabling it to continue its mission of offering specialized R&D support.

Recent News & Mentions

Feb 4, 2026FundingHuaguan Biotechnology - Series C

Financial History

Huaguan Biotechnology has raised $14.4M across 1 funding round. Most recently, it raised $14.4M Series C in February 2026.

Total Raised

$14.4M

Valuation

N/A

Funding Rounds Raised

Date	Round	Lead Investors	Other Investors
Feb 4, 2026	$14.4M Series C		Changjiang Capital, Changzhou Qihang Synthetic Biology Venture Capital Fund, SDIC Venture Capital, Shunxi Fund, Zhuhai Hengqin Softbank Xinchuang Equity Investment Management Enterprise

Financial History

Huaguan Biotechnology has raised $14.4M across 1 funding round.

Total Raised

$14.4M

Valuation

N/A

Deep Dive

Huaguan Biotechnology, headquartered in Beijing, China, is a specialized provider of integrated drug research and development services. Established in 2017, the company operates within the dynamic biotechnology sector, offering comprehensive solutions designed to support the complex process of pharmaceutical innovation. Its mission centers on delivering high-quality services to its clients, which have included organizations such as Sihuan Pharmaceutical.

The firm's expertise lies in its ability to offer end-to-end R&D support. This integrated approach ensures that clients can access a broad spectrum of services required for advancing drug candidates from discovery through various developmental stages. Huaguan Biotechnology's focus on quality aims to meet the stringent demands of the pharmaceutical industry.

As a key player in the Chinese biotechnology landscape, Huaguan Biotechnology contributes to the nation's scientific and medical progress. Its strategic location in Beijing places it within a vibrant hub for technological and scientific development, facilitating collaborations and access to talent.

Huaguan Biotechnology has demonstrated its financial viability and growth potential through successful fundraising initiatives. The company recently completed a Series C financing round, which secured hundreds of millions of RMB. This significant investment underscores investor confidence in its business model and its capacity for future expansion within the biotechnology market.

The capital raised from its Series C round is intended to bolster its operational capabilities, enhance its service offerings, and potentially expand its market reach. This funding enables Huaguan Biotechnology to continue its trajectory as a specialized service provider, supporting the development of new therapeutic solutions.

Sources

Frequently Asked Questions

What specific services does Huaguan Biotechnology offer within the biotechnology sector?

Huaguan Biotechnology specializes in providing integrated drug research and development services, offering comprehensive solutions across various stages of pharmaceutical development.

Which notable clients has Huaguan Biotechnology served?

Huaguan Biotechnology provides services to customers that have included Sihuan Pharmaceutical, among others.